Artificial Intelligence
Carecode Revolutionizes Brazilian Healthcare with AI-Powered Customer Service, Secures $4.3M Funding
Carecode, AI, Healthcare, Customer Service, Automation, Funding, Brazilian Healthcare
BenevolentAI Embarks on Strategic Overhaul to Realign with Founding TechBio Mission
BenevolentAI, strategic overhaul, TechBio mission, artificial intelligence, biopharmaceutical development, drug discovery, Kenneth Mulvany
Cleerly Secures $192M for Heart Attack-Predicting AI Technology
Cleerly, AI, Heart Disease, Coronary Artery Scanning, Funding
Iambic Therapeutics Enhances AI Suite with “Enchant” for Predictive Preclinical Drug Development
Iambic Therapeutics, AI, Enchant, preclinical predictive powers, drug discovery, clinical success prediction
Predictive Analytics and AI: Reducing Emergency Room Visits through Enhanced Triage and Resource Allocation
Predictive analytics, Artificial intelligence (AI), Emergency department (ED) visits, Triage, Resource allocation, Machine learning (ML), Healthcare optimization
AI-Driven Recognition of Disease Signatures in Cellular Pathway Visualizations
Artificial Intelligence (AI), Neural Networks, Disease Signatures, Cellular Pathway Visualizations, Transcriptomic Analysis, Machine Learning
Eli Lilly and insitro Collaborate on AI-Driven Metabolic Disease Therapies
Eli Lilly, insitro, AI, metabolic diseases, siRNA, GalNAc, drug discovery, biotechnology, pharmaceutical partnership
Eli Lilly and Insitro Collaborate on AI-Driven Therapies for Metabolic Diseases
Eli Lilly, Insitro, AI, Metabolic Diseases, Drug Development, Strategic Agreements, siRNA Therapies, Antibody Therapy, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Mendaera Secures $73M Series B Funding to Revolutionize Mainstream Medical Procedures with Robotics and AI
Mendaera, Series B funding, robotics, AI, medical procedures, healthcare technology, Threshold Ventures
Transforming Multiple Sclerosis Treatment: Emerging Trends and Future Directions
Multiple sclerosis, high-efficacy treatments, stem cell transplantation, disease-modifying therapies, personalized medicine, AI integration, myelin repair, neurorestorative therapies.